Synthetic Studies towards the Development of Psoralen-Acidic Retinoid Conjugates and Hybrids

Abstract

The chemical modification of trioxsalen using electrophilic aromatic substitution reactions, followed by either Wittig or Heck reactions or Suzuki coupling, allowed for ready access to C4′ modified trioxsalen derivatives that were successfully used for the preparation of a variety of trioxsalen conjugates with acitretin of either the polyamine or the ester type and trioxsalen-acitretin hybrids.

electrophilic aromatic substitution - Heck reaction - psoralen-retinoid conjugation - Suzuki coupling - Wittig reaction

References

1 Van der Kerkhof PCM. Neth. J. Med.  1998,  52:  40 ; and references cited therein

2 Krueger G. Ellis CN. J. Am. Acad. Dermatol.  2005,  53:  S94 ; and references cited therein

3 Leite VC. Santos RF. Chen LC. Guillo LA. J. Photochem. Photobiol., B  2004,  76:  49 ; and references cited therein

4 Gia O. Magno SM. Gonzalez-Diaz H. Quezada E. Santana L. Uriarte E. Via LD. Bioorg. Med. Chem.  2005,  13:  809 ; and references cited therein

5 Katz HI. Waalen J. Leach EE. J. Am. Acad. Dermatol.  1999,  41:  S7 ; and references cited therein

6 Pilkington T. Brogden RN. Drugs  1992,  43:  597 ; and references cited therein

7 Roenigk HH. J. Am. Acad. Dermatol.  1999,  41:  S18 ; and references cited therein

8 Van der Kerkhof PCM. Clin. Exp. Dermatol.  2001,  26:  356 ; and references cited therein

For a review on PACs see for example:

9a Karygiannis G. Papaioannou D. Eur. J. Org. Chem.  2000,  1841 

For some recent examples of medicinally interesting PACs see:

9b Camps P. Formosa X. Muñoz-Torrero D. Petrignet J. Badia A. Clos MV. J. Med. Chem.  2005,  48:  1701 

9c Cholody WM. Kosakowska-Cholody T. Hollingshead MG. Hariprakasha HK. Michejda CJ. J. Med. Chem.  2005,  48:  4474 

9d Nagarajan M. Morrell A. Antony S. Kohlhagen G. Agama K. Pommier Y. Ragazzon PA. Garbett NC. Chaires JB. Hollingshead M. Cushman M. J. Med. Chem.  2006,  49:  5129 

9e Oves D. Fernández S. Verlinden L. Bouillon R. Verstuyf A. Ferrero M. Gotor V. Bioorg. Med. Chem.  2006,  14:  7512 

9f Battaglia A. Guerrini A. Baldelli E. Fontana G. Varchi G. Samori C. Bombardelli E. Tetrahedron Lett.  2006,  47:  2667 

9g Wu D. Ji S. Wu Y. Ju Y. Zhao Y. Bioorg. Med. Chem. Lett.  2007,  17:  2983 

For the recent development of an α-methylene-γ-butyrolactone-psoralen bisamide heterodimer see:

9h Ropp S. Guy J. Berl V. Bischoff P. Lepoittevin J.-P. Bioorg. Med. Chem.  2004,  12:  3619 

For a recent example of an EC prodrug see:

10a Zakharian TY. Seryshev A. Sitharaman B. Gilbert BE. Knight V. Wilson BE. J. Am. Chem. Soc.  2005,  127:  12508 

See also:

10b Walsh JJ. Coughlan D. Heneghan N. Gaynor C. Bell A. Bioorg. Med. Chem. Lett.  2007,  17:  3599 

11 Tietze LF. Bell HP. Chandrasekhar S. Angew. Chem. Int. Ed.  2003,  42:  3996 ; and references cited therein

12 Papaioannou D, Drainas D, and Tsambaos D. inventors; WO  2004,018,001.  ; Chem. Abstr. 2004, 140, 235912

13a Isaacs ST. Shen C.-KJ. Hearst JE. Rapoport H. Biochemistry  1977,  16:  1058 

13b Kim K. Matsuura K. Kimizuka N. Bioorg. Med. Chem.  2007,  15:  4311 

For selected examples of other psoralen derivatives, their synthesis and mode of action, see ref. 4 above and:

14a Oliveira AMAG. Raposo MMM. Oloveira-Campos AMF. Machado AEH. Puapairoj P. Pedro M. Nascimento MSJ. Portela C. Afonso C. Pinto M. Eur. J. Med. Chem.  2006,  41:  367 

14b Chimichi S. Boccalini M. Cosimelli B. Viola G. Vedaldi D. Dall’Acqua F. Tetrahedron  2002,  58:  4859 

14c Traven VF. Kravtcenko DV. Chibisova TA. Shorshnev SV. Eliason R. Wakefield DH. Heterocycl. Commun.  1996,  2:  345 

14d Besson T. Ruiz N. Coudert G. Guillaumet G. Tetrahedron  1995,  51:  3197 

14e Bisagni E. J. Photochem. Photobiol., B  1992,  14:  23 ; and references cited therein

14f Zubía E. Luis FR. Massanet GM. Collado IG. Tetrahedron  1992,  48:  4239 

14g Confalone PN. Confalone DL. Tetrahedron  1981,  37:  1265 

15 Gaernter R. J. Am. Chem. Soc.  1952,  74:  5319 

16 Isaacs ST. Rapoport H. Hearst JE. J. Labelled Compd. Radiopharm.  1982,  XIX:  345 

17 Lambertin F. Wende M. Quirin MJ. Taran M. Delmond B. Eur. J. Org. Chem.  1999,  1489 

18 Travis RB. Sivakumar M. Olatunji Hollist G. Borhan B. Org. Lett.  2003,  5:  1031 

19 Kaufman KD. Worden LR. Lode ET. Strong MK. Reitz NC. J. Org. Chem.  1970,  35:  157 

20 Farrar MW. Levine R. J. Am. Chem. Soc.  1950,  72:  4433 

21a Ziegler CB. Heck RF. J. Org. Chem.  1978,  43:  2941 

21b Mikroyiannidis JA. Yu Y.-J. Lee S.-H. Jin J.-I. J. Polym. Sci., Part A: Polym. Chem.  2006,  44:  4494 

22 Bryan DB. Hall RF. Holden KG. Huffman WF. Gleason JG. J. Am. Chem. Soc.  1977,  99:  2353 

23 Trippett S. Walker DM. J. Chem. Soc.  1961,  1266 

24 Rafecas Jané L, Riera Escalé A, Écija Queralt M, Moyano Baldoire A, Comely A, and Casalprim Castellà I. inventors; WO  2006,067,216.  ; Chem. Abstr. 2006, 145, 103949

25 Geall AJ. Blagbrough IS. Tetrahedron  2000,  56:  2449